[IEEE 2014 International Symposium on Integrated Circuits (ISIC) - Singapore (2014.12.10-2014.12.12)] 2014 International Symposium on Integrated Circuits (ISIC) - A heterogeneous platform with GPU and FPGA for power efficient high performance computing
- 作者Wu, Qiang; Ha, Yajun; Kumar, Akash; Luo, Shaobo; Li, Ang; Mohamed, Shihab
- 文件大小275.38KB
- 发表时间2014
- DOI10.1109/isicir.2014.7029447
- 页码220-223
MK-5108, a Highly Selective Aurora-A Kinase Inhibitor, Shows Antitumor Activity Alone and in Combination with DocetaxelShimomura, T.; Hasako, S.; Nakatsuru, Y.; Mita, T.; Ichikawa, K.; Kodera, T.; Sakai, T.; Nambu, T.; Miyamoto, M.; Takahashi, I.; Miki, S.; Kawanishi, N.; Ohkubo, M.; Kotani, H.; Iwasawa, Y. · Molecular Cancer Therapeutics · 2010
TAS0728, a covalent-binding, HER2-selective kinase inhibitor shows potent antitumor activity in preclinical modelsIrie, Hiroki; Ito, Kimihiro; Fujioka, Yayoi; Oguchi, Kei; Fujioka, Akio; Hashimoto, Akihiro; Ohsawa, Hirokazu; Tanaka, Kenji; Funabashi, Kaoru; Araki, Hikari; Kawai, Yuichi; Shimamura, Tadashi; Wadhwa, Renu; Ohkubo, Shuichi; Matsuo, Kenichi · Molecular Cancer Therapeutics · 2019
A Novel, Selective Inhibitor of Fibroblast Growth Factor Receptors That Shows a Potent Broad Spectrum of Antitumor Activity in Several Tumor Xenograft ModelsZhao, G.; Li, W.-y.; Chen, D.; Henry, J. R.; Li, H.-Y.; Chen, Z.; Zia-Ebrahimi, M.; Bloem, L.; Zhai, Y.; Huss, K.; Peng, S.-b.; McCann, D. J. · Molecular Cancer Therapeutics · 2011
TAS4464, a highly potent and selective inhibitor of NEDD8 activating enzyme, suppresses neddylation and shows antitumor activity in diverse cancer modelsYoshimura, Chihoko; Muraoka, Hiromi; Ochiiwa, Hiroaki; Tsuji, Shingo; Hashimoto, Akihiro; Kazuno, Hiromi; Nakagawa, Fumio; Komiya, Yu; Suzuki, Satoshi; Takenaka, Toru; Kumazaki, Masafumi; Fujita, Naoya; Mizutani, Takashi; Ohkubo, Shuichi · Molecular Cancer Therapeutics · 2019
TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing RegimensHikichi, Y.; Honda, K.; Hikami, K.; Miyashita, H.; Kaieda, I.; Murai, S.; Uchiyama, N.; Hasegawa, M.; Kawamoto, T.; Sato, T.; Ichikawa, T.; Cao, S.; Nie, Z.; Zhang, L.; Yang, J.; Kuida, K.; Kupperman, E. · Molecular Cancer Therapeutics · 2012
Cell Lines Often MisidentifiedLewin, P L; Petrov, L A; Hao, L · Cancer Discovery · 2012
In This IssueCancer Discovery · 2012
Glioblastoma Can Arise from Differentiated CellsCancer Discovery · 2012
A Deeper Look at Tumor HeterogeneityCancer Discovery · 2012
Circulating Tumor Cells Predict Drug ResponseCancer Discovery · 2013
Forecast: Rough Seas for LeukemiaHockenbery, D. M. · Cancer Discovery · 2014
Hypoxia Signaling--License to MetastasizeVanharanta, S.; Massague, J. · Cancer Discovery · 2013
Functional Subtyping of Breast CancerBeijersbergen, R. L.; Bernards, R. · Cancer Discovery · 2011